LKT Labs

Biochemicals for Life Science Research

Canertinib Dihydrochloride

Canertinib Dihydrochloride

Product ID C0252
Cas No. 289499-45-2
Purity ≥98%
Product Unit SizeCostQuantityStock
25 mg $98.90 Please Inquire
100 mg $296.70 In stock
250 mg $593.30 In stock
Bulk Quote

Quicklinks

Description

Canertinib is an irreversible inhibitor of EGFR (HER2/ErbB). This compound is currently in clinical trials as an anticancer chemotherapeutic, displaying activity against a variety of cancers. In a cellular model of melanoma, canertinib exhibits cytostatic activity, stopping cell growth in the G1 phase, but not inducing apoptosis except at very high concentrations. In a related animal model, canertinib inhibits tumor growth. Separately, canertinib inhibits Akt and ERK1/2 in cells lacking ErbB receptors and induces caspase-mediated apoptosis.

Product Info

Cas No.

289499-45-2
Purity

≥98%
Formula

C24H25ClFN5O3 • 2HCl
Formula Wt.

558.86
IUPAC Name

N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6- yl]prop-2-enamide;dihydrochloride
Synonym

CI1033
Appearance

Pale yellow powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

C0252 MSDS PDF
Info Sheet

C0252 Info Sheet PDF
Brochures

PI3K-Akt-mTORC Pathway Booklet

Ras-Raf-MEK-ERK Pathway Booklet

References

Djerf Severinsson EA, Trinks C, Gréen H, et al. The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo. Biochem Biophys Res Commun. 2011 Oct 28;414(3):563-8. PMID: 21982771.

Trinks C, Severinsson EA, Holmlund B, et al. The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells. Biochem Biophys Res Commun. 2011 Jul 8;410(3):422-7. PMID: 21669187.

Zinner RG, Nemunaitis J, Eiseman I, et al. Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer. Clin Cancer Res. 2007 May 15;13(10):3006-14. PMID: 17505003.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T0106

    Xylosyltaxol

    Taxane found in species of Taxus; potential microt...
    ≥98%
  • G1849

    Gemifloxacin Mesylate

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%
  • V3277

    Vitamin E

    Synthetic vitamin E, antioxidant.
    ≥98%
  • C4000

    CK-636

    Arp2/3 inhibitor.
    ≥98%
  • M2077

    1-Methoxy-5-methylphenazinium Methyl Sulfate

    Electron carrier used to study dehydrogenase elect...
    ≥98%
  • R3220

    Rifampicin

    Ansamycin; bacterial DNA-dependent RNA polymerase ...
    ≥98%
  • A044178

    Abemaciclib mesylate

    CDK inhibitor.
    ≥98%
  • D564090

    7-epi-Docetaxel

    7-epi-Docetaxel is an impurity (impurity C) in the...
    ≥95%
  • S3352

    Sinefungin

    S-adenosylmethionine nucleoside analog; methyltran...
    ≥95%
  • S8013

    [Tyr8]-Substance P

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%
  • AS108

    Kudzu Flavonoid Standards Kit

    Kudzu Flavonoid Standards Kit Contents: -Column: C...
  • B6808

    [Des-Pro2]-Bradykinin

    Natriuretic, vasodilatory peptide, bradykinin anal...
    ≥95%
  • E6470

    Eprinomectin

    Semi-synthetic avermectin; GABA potentiator.
    ≥45%
  • S0225

    SAG Dihydrochloride

    Smoothened agonist.
    ≥98%
  • T2934

    Thiamphenicol Palmitate

    Chloramphenicol derivative; protein translation in...
    ≥98%
  • A4851

    β-Amyloid Peptide (1-40), rat

    Endogenous APP peptide cleavage product, primary c...
    ≥95%
  • R0247

    Raltegravir

    HIV integrase inhibitor.
    ≥99%
  • A0921

    N-Acetyl-D-Leucine

    D-amino acid, incorporated into bacterial cell wal...
    ≥98%
  • D5868

    Doramapimod

    JNK, ALK, p38 MAPK inhibitor.
    ≥98%
  • B0246

    Balofloxacin Dihydrate

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%